XML 100 R84.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule I - Condensed Financial information of Parent (Coupang, Inc.) - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating activities      
Net cash used in operating activities $ 565,439 $ (410,578) $ 301,554
Investing activities      
Net cash used in investing activities (848,254) (675,525) (520,654)
Financing activities      
Repurchase of common units and preferred units 0 0 (97,043)
Deferred offering costs paid 0 (11,618) 0
Proceeds from issuance of common stock/units, equity-based compensation plan 17,774 62,281 28,613
Net cash provided by financing activities 247,352 3,576,850 178,502
Cash and cash equivalents      
Net (decrease) increase in cash and cash equivalents, and restricted cash (123,073) 2,409,045 29,767
Cash and cash equivalents, and restricted cash, as of beginning of period 3,810,347 1,401,302 1,371,535
Cash and cash equivalents, and restricted cash, as of end of period 3,687,274 3,810,347 1,401,302
Parent Company      
Operating activities      
Net cash used in operating activities (79,277) (57,783) (7,587)
Investing activities      
Capital contribution to subsidiaries (725,400) (1,273,629) (184,490)
Return of capital contribution from subsidiaries 80,434 202,834 253,921
Net cash used in investing activities (644,966) (1,070,795) 69,431
Financing activities      
Repurchase of common units and preferred units 0 0 (97,043)
Proceeds from issuance of common units and preferred units, net of issuance costs 0 3,431,277 28,613
Deferred offering costs paid 0 (11,618) 0
Proceeds from issuance of common stock/units, equity-based compensation plan 17,774 62,281 0
Other, net 0 (1,663) 0
Net cash provided by financing activities 17,774 3,480,277 (68,430)
Cash and cash equivalents      
Net (decrease) increase in cash and cash equivalents, and restricted cash (706,469) 2,351,699 (6,586)
Cash and cash equivalents, and restricted cash, as of beginning of period 2,358,035 6,336 12,922
Cash and cash equivalents, and restricted cash, as of end of period $ 1,651,566 $ 2,358,035 $ 6,336